[go: up one dir, main page]

FI770254A - - Google Patents

Info

Publication number
FI770254A
FI770254A FI770254A FI770254A FI770254A FI 770254 A FI770254 A FI 770254A FI 770254 A FI770254 A FI 770254A FI 770254 A FI770254 A FI 770254A FI 770254 A FI770254 A FI 770254A
Authority
FI
Finland
Application number
FI770254A
Other languages
Finnish (fi)
Other versions
FI70228C (en
FI70228B (en
Inventor
Samuel Wilkinson
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB2900/76A external-priority patent/GB1577114A/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI770254A publication Critical patent/FI770254A/fi
Application granted granted Critical
Publication of FI70228B publication Critical patent/FI70228B/en
Publication of FI70228C publication Critical patent/FI70228C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C07K14/702—Enkephalins with at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI770254A 1976-01-26 1977-01-26 FRAMEWORK FOR FRAMSTAELLNING AV EN ENKEFALIN ANALOG PEPTID FI70228C (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB290076 1976-01-26
GB2900/76A GB1577114A (en) 1976-01-26 1976-01-26 Biologically active peptides
GB848176 1976-03-03
GB848176 1976-03-03
GB4882176 1976-11-23
GB4882176 1976-11-23

Publications (3)

Publication Number Publication Date
FI770254A true FI770254A (en) 1977-07-27
FI70228B FI70228B (en) 1986-02-28
FI70228C FI70228C (en) 1986-09-15

Family

ID=27254145

Family Applications (1)

Application Number Title Priority Date Filing Date
FI770254A FI70228C (en) 1976-01-26 1977-01-26 FRAMEWORK FOR FRAMSTAELLNING AV EN ENKEFALIN ANALOG PEPTID

Country Status (11)

Country Link
JP (1) JPS5291839A (en)
CH (1) CH644352A5 (en)
DE (1) DE2703109A1 (en)
DK (1) DK33177A (en)
ES (1) ES455365A1 (en)
FI (1) FI70228C (en)
FR (1) FR2338925A1 (en)
HU (1) HU184704B (en)
IL (1) IL51332A (en)
NL (1) NL7700785A (en)
SE (1) SE7708404L (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003000A (en) * 1975-05-27 1977-01-11 Sperry Rand Corporation Sinusoidal oscillator with electronically variable frequency
US4261888A (en) * 1976-04-12 1981-04-14 Sandoz Ltd. Organic compounds
FR2359817A1 (en) * 1976-07-27 1978-02-24 Reckitt & Colmann Prod Ltd Peptide cpds. contg. tyrosine, glycine, phenylalanine and d-amino acid - local anaesthetics, smooth muscle relaxants, adrenergic neutron blockers, beta-stimulants etc.
GB1532148A (en) * 1976-08-09 1978-11-15 Searle & Co 1-substituted enkepholin derivatives
HU178001B (en) * 1976-09-16 1982-02-28 Gyogyszekutato Intezet Process for preparing new pentapeptides with morphine-like activity and derivatives thereof
DE2819277A1 (en) * 1977-05-16 1978-11-23 Sandoz Ag NEW POLYPEPTIDE DERIVATIVES, THEIR PRODUCTION AND USE
GB2000784B (en) * 1977-07-05 1982-01-20 American Home Prod Analgesic polypetide
DE2862327D1 (en) * 1977-07-22 1983-11-10 Wellcome Found Pentapeptide-n-alkylamides and their acid addition salts, methods for preparation of these compounds and pharmaceutical formulations containing them
US4264491A (en) * 1977-10-03 1981-04-28 Eli Lilly And Company Analgesic compounds
HU182051B (en) * 1978-05-02 1983-12-28 Takeda Chemical Industries Ltd Process for preparing tetrapeptide-hydrazyde derivatives
US4278596A (en) * 1978-08-08 1981-07-14 American Home Products Corporation Analgesic pentapeptides
CA1175810A (en) * 1979-03-30 1984-10-09 Frank A. Momany Synthetic peptides having pituitary growth hormone releasing activity
US4247543A (en) * 1979-04-09 1981-01-27 Sandoz Ltd. Organic compounds
US4396606A (en) * 1979-11-05 1983-08-02 Addiction Research Foundation Novel polypeptide analgesics
EP0044451B1 (en) * 1980-07-17 1984-04-18 Sandoz Ag Novel pentapeptides, processes for their production, pharmaceutical compositions comprising said pentapeptides and their use
FR2488253A1 (en) * 1980-08-08 1982-02-12 Roques Bernard NEW PEPTIDES AND THEIR THERAPEUTIC APPLICATION
JPS58501861A (en) * 1981-12-28 1983-11-04 ベツクマン・インストルメンツ・インコ−ポレ−テツド Synthetic peptide with pituitary growth hormone-releasing activity
US4491541A (en) * 1982-11-10 1985-01-01 Farmitalia Carlo Erba Peptides
JPH0680079B2 (en) * 1984-11-09 1994-10-12 エーザイ株式会社 Polypeptide
AU618029B2 (en) * 1987-11-02 1991-12-12 Imperial Chemical Industries Plc Polypeptide compounds
EP0644772B1 (en) * 1992-11-12 2003-04-02 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Opioid peptides
WO2010120691A2 (en) * 2009-04-13 2010-10-21 Elc Management Llc Methionine sulfoxide peptide, compositions and methods of use
EP3681900A4 (en) 2017-09-11 2021-09-08 Protagonist Therapeutics, Inc. Opioid agonist peptides and uses thereof

Also Published As

Publication number Publication date
FR2338925A1 (en) 1977-08-19
SE7708404L (en) 1977-07-27
FR2338925B1 (en) 1980-08-08
JPS5291839A (en) 1977-08-02
IL51332A (en) 1980-09-16
CH644352A5 (en) 1984-07-31
FI70228C (en) 1986-09-15
HU184704B (en) 1984-10-29
FI70228B (en) 1986-02-28
NL7700785A (en) 1977-07-28
ES455365A1 (en) 1978-05-16
DE2703109A1 (en) 1977-08-04
DK33177A (en) 1977-07-27
IL51332A0 (en) 1977-03-31

Similar Documents

Publication Publication Date Title
FR2338925B1 (en)
FR2370320B1 (en)
JPS53595U (en)
JPS531678U (en)
JPS5588Y2 (en)
JPS576130B2 (en)
JPS5372206U (en)
JPS5616662Y2 (en)
JPS5622436Y2 (en)
JPS52145791U (en)
JPS5386748U (en)
JPS5295277U (en)
JPS52136104U (en)
JPS52121717U (en)
JPS52107673U (en)
CS177794B1 (en)
CS178348B1 (en)
CS178363B1 (en)
CS178372B1 (en)
DD123981A1 (en)
CH614808A5 (en)
DD125132A1 (en)
DD124295A1 (en)
DD125235A1 (en)
DD123950A1 (en)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: THE WELLCOME FOUNDATION LIMITED